Index S&P 500 P/E - EPS (ttm) -1.55 Insider Own 1.63% Shs Outstand 256.30M Perf Week -0.62%
Market Cap 16.82B Forward P/E 14.50 EPS next Y 4.53 Insider Trans 1.82% Shs Float 252.10M Perf Month -1.34%
Enterprise Value 22.88B PEG - EPS next Q 1.02 Inst Own 95.00% Short Float 1.83% Perf Quarter -16.27%
Income -393.00M P/S 1.49 EPS this Y -1.34% Inst Trans 0.19% Short Ratio 2.36 Perf Half Y -17.12%
Sales 11.30B P/B 1.17 EPS next Y 6.43% ROA -1.41% Short Interest 4.61M Perf YTD -22.39%
Book/sh 56.20 P/C 20.61 EPS next 5Y 5.13% ROE -2.74% 52W High 106.77 -38.54% Perf Year -36.17%
Cash/sh 3.18 P/FCF 30.03 EPS past 3/5Y -4.88% -24.99% ROIC -1.90% 52W Low 62.33 5.28% Perf 3Y -42.04%
Dividend Est. 1.64 (2.49%) EV/EBITDA 10.64 Sales past 3/5Y -0.49% 17.44%Gross Margin 31.12% Volatility 2.23% 1.91% Perf 5Y -46.70%
Dividend TTM 1.60 (2.44%) EV/Sales 2.02 EPS Y/Y TTM 83.36% Oper. Margin 10.07% ATR (14) 1.51 Perf 10Y -40.05%
Dividend Ex-Date Sep 29, 2025 Quick Ratio 1.10 Sales Y/Y TTM -0.07% Profit Margin -3.48% RSI (14) 43.05 Recom 1.83
Dividend Gr. 3/5Y -19.96% -11.58% Current Ratio 1.85 EPS Q/Q 258.58% SMA20 -0.87% Beta 1.11 Target Price 83.61
Payout 168.56% Debt/Eq 0.48 Sales Q/Q -4.33% SMA50 -6.11% Rel Volume 0.98 Prev Close 66.35
Employees 22400 LT Debt/Eq 0.43 Earnings Aug 05 AMC SMA200 -15.66% Avg Volume 1.96M Price 65.62
IPO Mar 02, 1964 Option/Short Yes / Yes EPS/Sales Surpr. 2.56% 2.28% Trades
Volume 1,921,159 Change -1.10%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-08-25 Upgrade Wolfe Research
Underperform → Peer Perform
Aug-07-25 Downgrade Oppenheimer
Outperform → Perform
Jun-04-25 Initiated Tigress Financial
Buy
$105
May-08-25 Upgrade Barclays
Equal Weight → Overweight
$84
Feb-20-25 Downgrade CFRA
Buy → Sell
$77
Jan-07-25 Upgrade Argus
Hold → Buy
Nov-12-24 Upgrade Morgan Stanley
Equal-Weight → Overweight
$111 → $110
Nov-08-24 Upgrade BofA Securities
Neutral → Buy
$107
Nov-07-24 Upgrade Vertical Research
Hold → Buy
$109
Sep-11-24 Reiterated Oppenheimer
Outperform
$116 → $117
Sep-03-24 Upgrade Mizuho
Neutral → Outperform
$109 → $120
Jul-22-24 Upgrade Stifel
Hold → Buy
$95 → $115
Jun-07-24 Initiated Oppenheimer
Outperform
$116
May-21-24 Downgrade Morgan Stanley
Overweight → Equal-Weight
$100
May-08-24 Upgrade JP Morgan
Neutral → Overweight
$75 → $100
Apr-18-24 Upgrade Barclays
Underweight → Equal Weight
Apr-10-24 Upgrade Citigroup
Neutral → Buy
$81 → $100
Mar-08-24 Downgrade Argus
Buy → Hold
Mar-01-24 Initiated Wolfe Research
Underperform
Jan-22-24 Upgrade Morgan Stanley
Equal-Weight → Overweight
$81 → $90
Show Previous Ratings
Sep-10-25 05:21AM
Sep-09-25 07:00AM
Sep-08-25 12:07PM
05:00AM
Sep-04-25 07:00AM
07:00AM
Loading…
Sep-02-25 07:00AM
Aug-27-25 04:00AM
Aug-19-25 08:05AM
Aug-15-25 12:02PM
Aug-13-25 04:15PM
07:00AM
Aug-11-25 09:15AM
Aug-07-25 04:30AM
Aug-06-25 12:55PM
11:02AM
06:00PM
Loading…
Aug-05-25 06:00PM
05:25PM
04:26PM
(Associated Press Finance)
04:15PM
Aug-01-25 12:35PM
Jul-31-25 07:42PM
Jul-30-25 04:20PM
04:15PM
Jul-29-25 10:00AM
Jul-24-25 06:00AM
Jul-18-25 07:08AM
Jul-17-25 06:47AM
02:59AM
Jul-16-25 01:53PM
12:07PM
11:48AM
Loading…
Jul-10-25 11:48AM
12:00AM
Jul-09-25 04:15PM
Jul-02-25 04:15AM
Jun-26-25 03:53PM
04:00AM
Jun-25-25 11:00AM
Jun-24-25 03:13PM
10:57AM
Jun-23-25 06:00AM
Jun-17-25 02:37PM
Jun-11-25 11:30AM
Jun-09-25 05:46PM
Jun-04-25 11:00AM
May-30-25 08:44AM
May-29-25 09:36AM
May-23-25 09:03AM
May-16-25 05:17PM
06:30AM
May-13-25 09:16AM
May-09-25 08:00AM
May-08-25 03:15AM
12:10AM
(Thomson Reuters StreetEvents)
May-07-25 05:19PM
12:13PM
12:03PM
12:03PM
11:21AM
May-06-25 06:00PM
05:30PM
04:20PM
May-02-25 10:56AM
09:10AM
May-01-25 06:00PM
04:15PM
12:18PM
09:15AM
02:00AM
Apr-29-25 10:01AM
Apr-28-25 05:00PM
08:00AM
Apr-23-25 08:21PM
Apr-22-25 02:00AM
Apr-16-25 08:54AM
12:00AM
Apr-14-25 04:15PM
09:02AM
Apr-10-25 09:11AM
08:00AM
Apr-09-25 08:00AM
Apr-08-25 07:23PM
(Morningstar Research) -5.46%
08:00AM
Apr-03-25 03:30PM
01:43PM
Apr-01-25 03:00AM
Mar-30-25 08:41AM
Mar-27-25 04:45PM
02:00AM
Mar-24-25 07:00PM
01:24PM
Mar-20-25 11:30AM
Mar-10-25 08:00PM
Mar-05-25 04:15PM
Mar-03-25 12:37AM
Feb-27-25 02:54PM
Feb-25-25 07:00AM
Feb-21-25 05:22AM
Feb-20-25 05:11PM
04:30PM
02:06AM
International Flavors & Fragrances, Inc. engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish segment consists of legacy Taste segment combined with N&B's Food & Beverage division and the food protection business of N&B's Health & Biosciences division. The Health & Biosciences business consists of a biotechnology-driven portfolio of enzymes, food cultures, probiotics and specialty ingredients for food, home and personal care, and health and wellness applications. The Scent business creates fragrance compounds, fragrance ingredients and cosmetic ingredients that are integral elements in the world's finest perfumes and best-known household and personal care products. The Pharma Solutions business produces a vast portfolio including cellulosics and seaweed-based pharma excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling. The company was founded in 1833 and is headquartered in New York, NY.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Borg Deborah EVP, Chief Ppl&Culture Officer Sep 02 '25 Option Exercise 0.00 13,808 0 41,288 Sep 03 06:16 PM FRIBOURG PAUL J Director Aug 07 '25 Buy 64.80 15,450 1,001,183 15,450 Aug 08 06:49 PM Fyrwald J Erik Chief Executive Officer Aug 07 '25 Buy 64.95 15,300 993,714 77,370 Aug 07 06:59 PM Teles de Mendonca Ana Paula President, Scent Jun 02 '25 Option Exercise 0.00 643 0 3,088 Jun 04 05:38 PM Arora Yuvraj President, Taste & CCO May 05 '25 Option Exercise 0.00 17,309 0 22,291 Jun 04 05:27 PM Arora Yuvraj President, Taste & CCO May 01 '25 Option Exercise 0.00 3,572 0 6,810 Jun 04 05:27 PM O'Byrne Kevin Director May 22 '25 Buy 76.05 4,500 342,240 7,696 May 23 04:46 PM Teles de Mendonca Ana Paula President, Scent May 05 '25 Option Exercise 0.00 1,498 0 3,210 May 22 07:30 PM Teles de Mendonca Ana Paula President, Scent May 01 '25 Option Exercise 0.00 1,587 0 2,523 May 22 07:30 PM Palau Hernandez Margarita Director May 19 '25 Buy 77.42 850 65,807 2,393 May 20 01:33 PM Yildiz Beril CAO, SVP & Controller May 19 '25 Sale 77.33 2,400 185,604 3,321 May 19 05:09 PM Landsman Stephen N EVP, General Counsel May 19 '25 Buy 77.28 12,000 927,356 12,000 May 19 05:08 PM Yildiz Beril Officer May 19 '25 Proposed Sale 77.33 2,400 185,604 May 19 01:12 PM Yildiz Beril CAO, SVP & Controller May 05 '25 Option Exercise 0.00 849 0 6,028 May 16 09:01 PM Yildiz Beril CAO, SVP & Controller May 01 '25 Option Exercise 0.00 952 0 5,523 May 16 09:01 PM Finzel Ralf EVP, Global Operations Officer May 05 '25 Option Exercise 0.00 1,326 0 9,976 May 16 09:01 PM Finzel Ralf EVP, Global Operations Officer May 01 '25 Option Exercise 0.00 1,984 0 9,663 May 16 09:01 PM DeVeau Michael EVP, CFO May 05 '25 Option Exercise 0.00 884 0 11,048 May 16 09:01 PM DeVeau Michael EVP, CFO May 01 '25 Option Exercise 0.00 1,389 0 10,874 May 16 09:01 PM Borg Deborah EVP, Chief Ppl&Culture Officer May 05 '25 Option Exercise 0.00 1,768 0 28,383 May 16 09:00 PM Borg Deborah EVP, Chief Ppl&Culture Officer May 01 '25 Option Exercise 0.00 2,381 0 27,817 May 16 09:00 PM Palau Hernandez Margarita Director May 01 '25 Option Exercise 0.00 1,543 0 1,543 May 16 08:57 PM O'Byrne Kevin Director May 01 '25 Option Exercise 0.00 1,875 0 3,590 May 16 08:56 PM Khan Mehmood Director May 15 '25 Buy 75.33 4,000 301,314 4,604 May 15 05:27 PM Fyrwald J Erik Chief Executive Officer May 09 '25 Buy 73.97 24,300 1,797,456 62,070 May 09 05:03 PM Fyrwald J Erik Chief Executive Officer May 08 '25 Buy 74.00 700 51,797 37,770 May 09 05:03 PM JAMISON CYNTHIA T Director May 01 '25 Option Exercise 0.00 604 0 604 May 05 05:51 PM INTRIERI VINCENT J Director May 01 '25 Option Exercise 0.00 604 0 604 May 05 05:50 PM Costa Mark J Director May 01 '25 Option Exercise 0.00 1,875 0 4,014 May 05 05:50 PM Khan Mehmood Director May 01 '25 Option Exercise 0.00 604 0 604 May 05 05:47 PM Fyrwald J Erik Chief Executive Officer May 01 '25 Option Exercise 0.00 15,875 0 45,175 May 05 05:46 PM Strzelecki Angela President, Pharma Solutions Apr 04 '25 Option Exercise 0.00 1,761 0 10,362 Apr 07 04:17 PM DeVeau Michael CFO Apr 04 '25 Option Exercise 0.00 1,993 0 10,204 Apr 07 04:16 PM Borg Deborah EVP, Chief Ppl&Culture Officer Apr 04 '25 Option Exercise 0.00 4,602 0 27,981 Apr 07 04:16 PM O'Byrne Kevin Director Mar 05 '25 Buy 80.44 6,500 522,833 6,500 Mar 06 05:13 PM Fyrwald J Erik CEO Mar 04 '25 Buy 80.24 25,000 2,005,878 29,300 Mar 05 04:08 PM Finzel Ralf EVP, Global Operations Officer Dec 02 '24 Option Exercise 0.00 5,387 0 9,622 Dec 03 04:05 PM Arora Yuvraj President, Nourish Nov 11 '24 Sale 91.75 5,000 458,775 3,238 Nov 12 04:20 PM Arora Yuvraj Officer Nov 11 '24 Proposed Sale 91.75 5,000 458,775 Nov 12 09:07 AM RICHTER GLENN R CFO Oct 01 '24 Option Exercise 0.00 11,812 0 32,171 Oct 03 04:20 PM
